Calcium channel blockers not found to increase risk of breast cancer
the ONA take:
According to findings presented at the 2014 American Heart Association Scientific in Chicago, Illinois, researchers from the Intermountain Medical Center Heart Institute in Murray, Utah, have found that women who take calcium channel blockers to treat their hypertension are not at increased risk for developing breast cancer.
Prompted by a study conducted last year at the Fred Hutchinson Cancer Research Center in Seattle, Washington, researchers conducted two studies by analyzing data from the records of more than 3,700 women ages 50 to 70 years with no history of breast cancer who had used calcium channel blockers long-term to treat their high blood pressure.
For each study, researchers compared women who had long-term use of calcium channel blockers to similar women who did not take those medications. In one study, they found a slight increase in breast cancer risk, and a 50% decreased risk in the second study.
The second study's findings were significant, but the odds of breast cancer were much lower than those observed in the study at Fred Hutchinson. As a result, the researchers recommend the continued use of calcium channel blockers to treat hypertension, thereby reducing the risk of myocardial infarction and stroke.
Women who take calcium channel blockers to treat their hypertension are not at increased risk.
Researchers analyzed the records of more than 3,700 women who had no history of breast cancer, and who had long-term use of calcium channel blocker medications to control their blood pressure. Researchers found only a minimal increase in risk in one study and a 50 percent reduced risk in a second, leading them to recommend the continued use of these important medications to help prevent heart attack and stroke.
Findings from the Intermountain Medical Center Heart Institute study will be presented at the 2014 American Heart Association Scientific in Chicago at 10:30, EST, on Wednesday, November 19.
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Baseline PSA Levels in Midlife Could Predict Risk of Lethal Prostate Cancer
- Community Breast Navigation Program Improved Breast Screening Rates in Underserved African American and Latino Women
- Live-streamed Videos Address End-of-Life Planning, Decision-making
- Metastatic Disease Linked to Patients Reporting Diminished QoL
- History of Bilateral Salpingo-oophorectomy, Hormone Replacement Therapy Are Predictive of Breast Density at Cancer Diagnosis
- Mammographically Occult Contralateral Breast Cancer Detection is Effective With Preoperative MRI
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|